Human GM-CSF antigen binding proteins

Details for Australian Patent Application No. 2008302747 (hide)

Owner Amgen Inc.

Inventors Barone, Dauphine; Olson, Kara; Escobar, Jose Carlos; Brasel, Kenneth A.; Kirchner, Jacqueline A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008302747

PCT Pub. Number WO2009/038760

Priority 61/087,551 08.08.08 US; 60/994,343 18.09.07 US

Filing date 18 September 2008

Wipo publication date 26 March 2009

Acceptance publication date 2 February 2012

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/038760 Priority application(s): WO2009/038760

2 February 2012 Application Accepted

  Published as AU-B-2008302747

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008302751-Fluoro-containing derivatives of hydrogented pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use

2008302746-1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as SlP receptor modulators for the treatment of immune disorders